ES2265922T3 - Procedimiento para reducir la laxitud de la articulacion de la cadera. - Google Patents
Procedimiento para reducir la laxitud de la articulacion de la cadera. Download PDFInfo
- Publication number
- ES2265922T3 ES2265922T3 ES00913388T ES00913388T ES2265922T3 ES 2265922 T3 ES2265922 T3 ES 2265922T3 ES 00913388 T ES00913388 T ES 00913388T ES 00913388 T ES00913388 T ES 00913388T ES 2265922 T3 ES2265922 T3 ES 2265922T3
- Authority
- ES
- Spain
- Prior art keywords
- pyrophosphate
- composition
- food
- diet
- source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004394 hip joint Anatomy 0.000 title claims description 28
- 238000000034 method Methods 0.000 title description 21
- 239000000203 mixture Substances 0.000 claims abstract description 75
- 235000005911 diet Nutrition 0.000 claims abstract description 61
- 235000013305 food Nutrition 0.000 claims abstract description 61
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims abstract description 48
- 235000011180 diphosphates Nutrition 0.000 claims abstract description 48
- 230000037213 diet Effects 0.000 claims abstract description 43
- 241001465754 Metazoa Species 0.000 claims abstract description 26
- 230000000378 dietary effect Effects 0.000 claims abstract description 18
- 150000001450 anions Chemical class 0.000 claims abstract description 16
- 235000016709 nutrition Nutrition 0.000 claims abstract description 10
- 235000019982 sodium hexametaphosphate Nutrition 0.000 claims abstract description 10
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 claims abstract description 10
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims abstract description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 9
- 239000011734 sodium Substances 0.000 claims abstract description 9
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000000460 chlorine Substances 0.000 claims abstract 3
- 229910052801 chlorine Inorganic materials 0.000 claims abstract 3
- 239000011591 potassium Substances 0.000 claims abstract 3
- 229910052700 potassium Inorganic materials 0.000 claims abstract 3
- 241000282472 Canis lupus familiaris Species 0.000 claims description 65
- 239000000463 material Substances 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 235000019737 Animal fat Nutrition 0.000 claims description 11
- 230000009467 reduction Effects 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- 235000019820 disodium diphosphate Nutrition 0.000 claims description 3
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 claims description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 239000004519 grease Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000001125 extrusion Methods 0.000 claims 1
- 235000008935 nutritious Nutrition 0.000 claims 1
- 230000011218 segmentation Effects 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 description 25
- 210000000988 bone and bone Anatomy 0.000 description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 description 13
- 239000011707 mineral Substances 0.000 description 13
- 235000010755 mineral Nutrition 0.000 description 13
- 239000002245 particle Substances 0.000 description 13
- 230000012010 growth Effects 0.000 description 12
- 206010023204 Joint dislocation Diseases 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 210000001624 hip Anatomy 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 201000008482 osteoarthritis Diseases 0.000 description 8
- 210000000588 acetabulum Anatomy 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 206010073767 Developmental hip dysplasia Diseases 0.000 description 5
- 208000007446 Hip Dislocation Diseases 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000018678 bone mineralization Effects 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 4
- 229940038472 dicalcium phosphate Drugs 0.000 description 4
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 241000282465 Canis Species 0.000 description 3
- 108010068370 Glutens Proteins 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 235000021312 gluten Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- -1 pyrophosphate compound Chemical class 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000006558 Dental Calculus Diseases 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000036426 canine hip dysplasia Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
- 235000020940 control diet Nutrition 0.000 description 2
- 235000014510 cooky Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241001350860 Glena Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000005137 Joint instability Diseases 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/26—Compounds containing phosphorus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US247763 | 1999-02-09 | ||
| US09/247,763 US6261591B1 (en) | 1999-02-09 | 1999-02-09 | Method for reducing hip joint laxity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2265922T3 true ES2265922T3 (es) | 2007-03-01 |
Family
ID=22936269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00913388T Expired - Lifetime ES2265922T3 (es) | 1999-02-09 | 2000-02-08 | Procedimiento para reducir la laxitud de la articulacion de la cadera. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6261591B1 (enExample) |
| EP (1) | EP1150569B1 (enExample) |
| JP (2) | JP4080695B2 (enExample) |
| KR (1) | KR100676589B1 (enExample) |
| AU (1) | AU776992B2 (enExample) |
| BR (1) | BR0008089A (enExample) |
| CA (1) | CA2359874C (enExample) |
| DE (1) | DE60028935T2 (enExample) |
| ES (1) | ES2265922T3 (enExample) |
| HK (1) | HK1040592B (enExample) |
| HU (1) | HUP0105485A2 (enExample) |
| PL (1) | PL202206B1 (enExample) |
| WO (1) | WO2000047049A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1158868B1 (en) * | 1999-03-05 | 2004-06-16 | The Iams Company | Process for preserving skeletal muscle mass in geriatric dogs |
| US6582752B2 (en) * | 2001-11-02 | 2003-06-24 | Nestec, Ltd | Methods and compositions for a gender specific diet for puppies |
| EP1617805A4 (en) * | 2003-04-11 | 2012-07-04 | Medimmune Llc | METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS |
| US9827314B2 (en) | 2003-12-08 | 2017-11-28 | Mars, Incorporated | Edible compositions which are adapted for use by a companion animal |
| US8529965B2 (en) | 2007-07-09 | 2013-09-10 | Hill's Pet Nutrition, Inc. | Compositions and methods for altering stool quality in an animal |
| EP2178391B1 (en) * | 2007-07-09 | 2014-06-04 | Hill's Pet Nutrition, Inc. | Compositions and methods for altering stool quality in an animal |
| GB201120989D0 (en) | 2011-12-06 | 2012-01-18 | Mars Inc | Genetic test |
| EP3081265A1 (en) | 2012-04-17 | 2016-10-19 | Big Heart Pet Brands | Appetizing and dentally efficacious animal chews |
| US9737053B2 (en) | 2012-04-17 | 2017-08-22 | Big Heart Pet, Inc. | Methods for making appetizing and dentally efficacious animal chews |
| GB201310558D0 (en) | 2013-06-13 | 2013-07-31 | Mars Inc | Genetic test |
| JP5911918B2 (ja) * | 2014-06-30 | 2016-04-27 | ユニ・チャーム株式会社 | ペットフードの製造方法 |
| JP2022540664A (ja) * | 2019-07-12 | 2022-09-16 | スティヒティング・ヘット・ネーデルランズ・カンカー・インスティテュート－アントニ・ファン・レーウェンフック・ゼィークンホイス | 石灰化減少に用いる経口ピロリン酸二ナトリウム |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1143399A (en) * | 1965-10-29 | 1969-02-19 | Jack Leonard Harvey | Improvements relating to foods for pet animals |
| US4044158A (en) | 1975-07-23 | 1977-08-23 | The Quaker Oats Company | Caseinate replacement for pet food using a neutral chelating agent |
| US4127678A (en) | 1975-07-23 | 1978-11-28 | The Quaker Oats Company | Caseinate replacement in semi-moist pet foods |
| US4039689A (en) | 1976-02-03 | 1977-08-02 | The Quaker Oats Company | Soft dry pet food product and process |
| US4276311A (en) | 1976-06-17 | 1981-06-30 | Mars Limited | Food product and process |
| US4267195A (en) | 1976-09-10 | 1981-05-12 | University Of Texas | Dog food flavors |
| US4215149A (en) | 1978-11-17 | 1980-07-29 | Standard Brands Incorporated | Process for improving the palatability of pet food |
| JPS5944019B2 (ja) | 1979-09-14 | 1984-10-26 | 株式会社上野製薬応用研究所 | 保存性の良好な中湿度飼料の製造法 |
| US4514431A (en) | 1983-06-23 | 1985-04-30 | International Flavors & Fragrances Inc. | Enhancing the taste of a meat-flavored foodstuff |
| GB8502124D0 (en) | 1985-01-29 | 1985-02-27 | Spillers Foods Ltd | Pet food |
| US4806340A (en) | 1985-09-13 | 1989-02-21 | Colgate-Palmolive Company | Anticalculus oral composition |
| US4772476A (en) | 1986-03-12 | 1988-09-20 | Ralston Purina Company | Method for reducing the severity of hip joint laxity in dogs |
| US5114704A (en) | 1989-05-30 | 1992-05-19 | Nabisco Brands, Inc. | Raw hide having a coating containing an inorganic pyrophosphate |
| US5015485A (en) | 1989-05-30 | 1991-05-14 | Nabisco Brands, Inc. | Dog biscuits having a coating containing an inorganic pyrophosphate |
| US5047231A (en) | 1989-05-30 | 1991-09-10 | Nabisco Brands, Inc. | Raw hide containing an inorganic pyrophosphate |
| US5000940A (en) | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Devices, compositions and the like having or containing an inorganic pyrophosphate |
| US5000943A (en) | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Canine biscuits containing an inorganic pyrophosphate |
| US5011679A (en) | 1989-05-30 | 1991-04-30 | Nabisco Brands, Inc. | Raw hide having a coating containing an inorganic pyrophosphate |
| US5094870A (en) | 1989-05-30 | 1992-03-10 | Nabisco Brands, Inc. | Canine biscuits containing an inorganic pyrophosphate |
| US5000973A (en) | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Nutritionally-balanced canine biscuits containing an inorganic pyrophosphate |
| US5000490A (en) * | 1989-12-11 | 1991-03-19 | Albrecht David E | Adapter fitting |
| US5186964A (en) | 1990-09-04 | 1993-02-16 | Applied Food Biotechnology, Inc. | Flavor composition for pet food |
| US5296209A (en) | 1992-01-17 | 1994-03-22 | Colgate Palmolive Company | Pet chew product having oral care properties |
| US5391743A (en) | 1992-05-29 | 1995-02-21 | Procter & Gamble Pharmaceuticals, Inc. | Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque |
| US5296217A (en) | 1992-06-15 | 1994-03-22 | Indiana University Foundation | Methods for preventing dental calculus in domestic animals |
| US5618518A (en) | 1995-06-06 | 1997-04-08 | Indiana University Foundation | Methods and compositions for use against dental calculus in domestic animals |
-
1999
- 1999-02-09 US US09/247,763 patent/US6261591B1/en not_active Expired - Lifetime
-
2000
- 2000-02-08 WO PCT/US2000/003186 patent/WO2000047049A1/en not_active Ceased
- 2000-02-08 DE DE60028935T patent/DE60028935T2/de not_active Expired - Lifetime
- 2000-02-08 EP EP00913388A patent/EP1150569B1/en not_active Expired - Lifetime
- 2000-02-08 ES ES00913388T patent/ES2265922T3/es not_active Expired - Lifetime
- 2000-02-08 AU AU34845/00A patent/AU776992B2/en not_active Expired
- 2000-02-08 PL PL350157A patent/PL202206B1/pl not_active IP Right Cessation
- 2000-02-08 JP JP2000598009A patent/JP4080695B2/ja not_active Expired - Lifetime
- 2000-02-08 HU HU0105485A patent/HUP0105485A2/hu unknown
- 2000-02-08 BR BR0008089-6A patent/BR0008089A/pt not_active Application Discontinuation
- 2000-02-08 KR KR1020017009963A patent/KR100676589B1/ko not_active Expired - Fee Related
- 2000-02-08 HK HK02102174.2A patent/HK1040592B/en not_active IP Right Cessation
- 2000-02-08 CA CA002359874A patent/CA2359874C/en not_active Expired - Lifetime
-
2007
- 2007-07-23 JP JP2007191426A patent/JP4755150B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008017846A (ja) | 2008-01-31 |
| WO2000047049A1 (en) | 2000-08-17 |
| HK1040592A1 (en) | 2002-06-21 |
| EP1150569B1 (en) | 2006-06-21 |
| BR0008089A (pt) | 2001-11-06 |
| HUP0105485A2 (hu) | 2002-05-29 |
| JP4755150B2 (ja) | 2011-08-24 |
| HK1040592B (en) | 2007-01-19 |
| PL202206B1 (pl) | 2009-06-30 |
| JP2002536002A (ja) | 2002-10-29 |
| CA2359874C (en) | 2009-06-30 |
| KR100676589B1 (ko) | 2007-01-30 |
| AU3484500A (en) | 2000-08-29 |
| EP1150569A4 (en) | 2004-10-06 |
| KR20010101812A (ko) | 2001-11-14 |
| US6261591B1 (en) | 2001-07-17 |
| DE60028935D1 (de) | 2006-08-03 |
| CA2359874A1 (en) | 2000-08-17 |
| AU776992B2 (en) | 2004-09-30 |
| DE60028935T2 (de) | 2007-07-12 |
| PL350157A1 (en) | 2002-11-18 |
| EP1150569A1 (en) | 2001-11-07 |
| JP4080695B2 (ja) | 2008-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4755150B2 (ja) | 股関節弛緩の低減方法 | |
| ES2233360T3 (es) | Empleo de creatina como aditivo a piensos. | |
| JP2011006423A (ja) | 猫における甲状腺機能亢進症を予防する方法及び限定されたヨウ素を含む組成物 | |
| ES2384786T3 (es) | Métodos y composiciones para potenciar la sabrosidad del pienso para animales domésticos | |
| JP2012515002A (ja) | ピルビン酸およびその塩を含有する愛玩動物用組成物ならびにその使用方法 | |
| Fox et al. | Nutrition of the Ferret | |
| JP2006503567A (ja) | 高齢ネコ科動物フード | |
| US3911114A (en) | Composition and method for treating stressed ruminants | |
| JPH01153047A (ja) | 子豚、肥育豚及び家禽用の飼料 | |
| JP2007512848A (ja) | 動物の食欲またはフード摂取を調節することによって動物の体重を調節する食物非必須アミノ酸であるチロシン | |
| US4772476A (en) | Method for reducing the severity of hip joint laxity in dogs | |
| CA1058001A (en) | Sulfur as an anorexigenic agent | |
| AU2002319855A1 (en) | Tellurim containing product | |
| WO2003017778A2 (en) | Tellurium containing product | |
| MXPA01008039A (en) | Method for reducing hip joint laxity | |
| Dyer et al. | Special solvent cottonseed meal with and without a vitamin B12 supplement and streptomycin as a source of protein for pigs | |
| Sheffy et al. | Comparison of Growth Responses of 2-Day-Old Pigs to Streptomycin, Aureomycin, and Crude APF, Alone and in Combination with B12 | |
| CA1305351C (en) | Method and composition for reducing the severity of hip dysplasia in animals | |
| US11819040B2 (en) | Materials and methods for dietary calcium supplementation of animals | |
| Atwal et al. | Effects of season, dietary protein supplement and biotin on performance and pyruvate carboxylase activity in livers of poults | |
| JP2007504832A (ja) | 飼料用オレアミド含有組成物 | |
| Hogan et al. | Swine Reproduction as Affected by Restricted Quarters | |
| Godfrey | The pig's need for minerals | |
| US20040258802A1 (en) | Ingestible supplement for enhancing animal performance | |
| Reece et al. | EC92-210 Swine Diet Suggestions |